United States Food and Drug Administration (USFDA) has completed inspection at Solara Active Pharma Science’s manufacturing facility in Ambernath, in the state of Maharashtra with zero 483s inspectional observations. The company stays committed to demonstrating the highest level of compliance with yet another USFDA audit with ‘Zero 483s’.
Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.